These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 7980244

  • 1. Acute oxalate nephropathy after a massive intravenous dose of vitamin C.
    Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J.
    Aust N Z J Med; 1994 Aug; 24(4):410-1. PubMed ID: 7980244
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin C-induced oxalate nephropathy in a renal transplant patient related to excessive ingestion of cashew pseudofruit (Anacardium occidentale L.): a case report.
    Moyses-Neto M, Brito BRS, de Araújo Brito DJ, Barros NDC, Dantas M, Salgado-Filho N, Costa RS, Silva GEB.
    BMC Nephrol; 2018 Oct 12; 19(1):265. PubMed ID: 30314464
    [Abstract] [Full Text] [Related]

  • 3. Effects of ascorbate supplements on urinary oxalate and risk of kidney stones.
    Massey LK.
    J Am Diet Assoc; 2000 May 12; 100(5):516. PubMed ID: 10841663
    [No Abstract] [Full Text] [Related]

  • 4. Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms.
    Lin WV, Turin CG, McCormick DW, Haas C, Constantine G.
    CEN Case Rep; 2019 Feb 12; 8(1):67-70. PubMed ID: 30276648
    [Abstract] [Full Text] [Related]

  • 5. [Vitamin C and stone risk. Review of the literature].
    Traxer O, Pearle MS, Gattegno B, Thibault P.
    Prog Urol; 2003 Dec 12; 13(6):1290-4. PubMed ID: 15000301
    [Abstract] [Full Text] [Related]

  • 6. Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency.
    Fijen L, Weijmer M.
    BMJ Case Rep; 2019 Nov 19; 12(11):. PubMed ID: 31748360
    [Abstract] [Full Text] [Related]

  • 7. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis.
    Witte M, Tobon A, Gruenenfelder J, Goldfarb R, Coburn M.
    J Urol; 1998 Feb 19; 159(2):498-9. PubMed ID: 9649271
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation.
    Auer BL, Auer D, Rodgers AL.
    Clin Chem Lab Med; 1998 Mar 19; 36(3):143-7. PubMed ID: 9589801
    [Abstract] [Full Text] [Related]

  • 15. Ascorbic acid supplements and kidney stone incidence among men: a prospective study.
    Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A.
    JAMA Intern Med; 2013 Mar 11; 173(5):386-8. PubMed ID: 23381591
    [No Abstract] [Full Text] [Related]

  • 16. Oxalate nephropathy following vitamin C intake within intensive care unit
.
    Colliou E, Mari A, Delas A, Delarche A, Faguer S.
    Clin Nephrol; 2017 Dec 11; 88(12):354-358. PubMed ID: 29092737
    [Abstract] [Full Text] [Related]

  • 17. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis.
    Urivetzky M, Kessaris D, Smith AD.
    J Urol; 1992 May 11; 147(5):1215-8. PubMed ID: 1569652
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Case | Acute renal failure and a "rejuvenating powder".
    Borceux P, Aydin S, Demoulin N, Devresse A.
    Kidney Int; 2020 Jan 11; 97(1):219-220. PubMed ID: 31901348
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.